PMID- 22267299
OWN - NLM
STAT- MEDLINE
DCOM- 20120719
LR  - 20151119
IS  - 1945-1997 (Electronic)
IS  - 0098-6151 (Linking)
VI  - 112
IP  - 1 Suppl 1
DP  - 2012 Jan
TI  - Initiating a glucagon-like peptide-1 receptor agonist in the management of type 2 
      diabetes mellitus.
PG  - S16-21
AB  - Control of blood glucose levels and restoration of pancreatic islet function are 
      among the goals of physicians seeking to improve outcomes in patients with type 2 
      diabetes mellitus (T2DM). A growing body of evidence supports the use of 
      incretins to achieve these goals, and current guidelines recommend earlier and 
      more frequent use of these agents. However, in patients with T2DM, treatment 
      paradigms should always be individualized. The author discusses issues for 
      physicians to consider when adjusting T2DM therapy, including patient 
      comorbidities, glucose control patterns, and potential adverse effects. The 
      importance of patient education and practical points for initiating a 
      glucagon-like peptide-1 receptor agonist are also reviewed.
FAU - Gavin, James R 3rd
AU  - Gavin JR 3rd
AD  - Healing Our Village, Inc, Lanham, Maryland, USA. jrgavin3@yahoo.com
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - J Am Osteopath Assoc
JT  - The Journal of the American Osteopathic Association
JID - 7503065
RN  - 0 (Blood Glucose)
RN  - 0 (GLP1R protein, human)
RN  - 0 (Glucagon-Like Peptide-1 Receptor)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Receptors, Glucagon)
SB  - IM
MH  - Blood Glucose/drug effects/metabolism
MH  - Diabetes Mellitus, Type 2/blood/*drug therapy
MH  - *Disease Management
MH  - Glucagon-Like Peptide-1 Receptor
MH  - Humans
MH  - Hypoglycemic Agents/*therapeutic use
MH  - Receptors, Glucagon/*agonists/blood
EDAT- 2012/02/01 06:00
MHDA- 2012/07/20 06:00
CRDT- 2012/01/24 06:00
PHST- 2012/01/24 06:00 [entrez]
PHST- 2012/02/01 06:00 [pubmed]
PHST- 2012/07/20 06:00 [medline]
AID - 112/1_suppl_1/S16 [pii]
PST - ppublish
SO  - J Am Osteopath Assoc. 2012 Jan;112(1 Suppl 1):S16-21.